Prognosis and treatment of desquamative inflammatory vaginitis

Obstetrics and Gynecology

Volumn 117, Issue 4, 2011, Pages 850-855

  Sobel, Jack D ^a,b   Reichman, Orna ^a   Misra, Dawn ^a   Yoo, Wonsuk ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; CORTISONE ACETATE; FLUCONAZOLE; HYDROCORTISONE;

ADULT; ARTICLE; DESQUAMATION; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGINA CANDIDIASIS; VAGINITIS;

ADMINISTRATION, TOPICAL; ADULT; AGE FACTORS; CLINDAMYCIN; COHORT STUDIES; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROCORTISONE; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VULVOVAGINITIS;

EID: 79953173979     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182117c9e     Document Type: Article

References (15)

1. Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol 1994;171:1215-20. (Pubitemid 24365718)
2. Gardner HL. Desquamative inflammatory vaginitis: a newly defined entity. Am J Obstet Gynecol 1968;102:1102-5.
3. Gray LA, Barnes ML. Vaginitis in women, diagnosis and treatment. Am J Obstet Gynecol 1965;92:125-36.
4. Oates JK, Rowen D. Desquamative inflammatory vaginitis: a review. Genitourin Med 1990;66:275-9.
5. Zeger S, Liang KY. An overview of methods for the analysis of longitudinal data. Stat Med 1992;11:1825-39. (Pubitemid 23015633)
6. Toyoda M, Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology 1998;196:130-4. (Pubitemid 28116060)
7. Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 1978; 70:51-5. (Pubitemid 8262275)
8. Amsden GW. Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of communityacquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005;55: 10-21. (Pubitemid 40192609)
9. Majima Y. Clinical implications of the immunomodulatory effects of macrolides on sinusitis. Am J Med 2004;117(suppl 9A): 20S-25S
10. Schlü nzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 2001;413:814-21. (Pubitemid 33026843)
11. Schlievert PM, Kelly JA. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. J Infect Dis 1984;149:471. (Pubitemid 14138254)
12. Peterson PK, Schlievert PM, Conroy W, Kelly JA, Spika J, Quie PG. Protection against staphylococcal pyrogenic exotoxin type C-enhanced endotoxin lethality with methylprednisolone and IgG. J Infect Dis 1983;147:358. (Pubitemid 13195122)
13. Cooper SM, Haefner HK, Abrahams-Gessel S, Margesson LJ. Vulvovaginal lichen planus treatment: a survey of current practices. Arch Dermatol 2008;144:1520-1.
14. Edwards L, Friedrich EG Jr. Desquamative vaginitis: lichen planus in disguise. Obstet Gynecol 1988;71(6 pt 1):832-6.
15. Murphy R, Edwards L. Desquamative inflammatory vaginitis: what is it? J Reprod Med 2008;53:124-8.